ResMed

ResMed

Yahoo Finance • 6 days ago

ResMed (RMD): Buy, Sell, or Hold Post Q2 Earnings?

ResMed (RMD): Buy, Sell, or Hold Post Q2 Earnings? ResMed currently trades at $218.94 per share and has shown little upside over the past six months, posting a small loss of 2.7%. The stock also fell short of the S&P 500's 15.9% gain duri... Full story

Yahoo Finance • 19 days ago

Twist Bioscience (TWST) Expands AI Drug Discovery Exposure With Lilly TuneLab Partnership

Twist Bioscience Corporation (NASDAQ:TWST) is on the cusp of gaining significant exposure to the rapidly evolving artificial intelligence (AI)-driven drug discovery ecosystem. On September 16, the company confirmed a strategic partnership... Full story

Yahoo Finance • 26 days ago

Is Margin Pressure From Rising Costs Altering The Investment Case For ResMed (RMD)?

Earlier this year, ResMed reported quarterly results showing revenue of US$1.46 billion, up 8.6% year on year, with adjusted earnings per share ahead of expectations but accompanied by operating margin pressure from higher R&D and supply c... Full story

Yahoo Finance • 26 days ago

ResMed upgraded at RBC Capital Markets on Q4 positives

[ResMed headquarters in San Diego, CA, USA.] JHVEPhoto RBC Capital Markets on Tuesday upgraded ResMed (RMD [https://seekingalpha.com/symbol/RMD]) to Outperform from Sector Perform and raised its price target to $262 from $244, citing posi... Full story

Yahoo Finance • last month

Ten healthcare stocks leading in year-over-year CapEx growth

[Health Care Medical Stock Market Industry Sector Wall Street Buildings 3d Illustration] iQoncept/iStock via Getty Images With the second-quarter earnings season now largely behind us, investors are turning their attention to how healthca... Full story

Yahoo Finance • last month

Resmed Announces Participation in the 24th Annual Morgan Stanley Global Healthcare Conference

Resmed, Inc. SAN DIEGO, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chairman and chief executive officer, and Aaron Bloomer, chief financial officer, will attend the 24th Annual Morgan Stan... Full story

Yahoo Finance • last month

2 S&P 500 Stocks with Promising Prospects and 1 We Ignore

2 S&P 500 Stocks with Promising Prospects and 1 We Ignore While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor execution, weak financials,... Full story

Yahoo Finance • 2 months ago

The 5 Most Interesting Analyst Questions From ResMed’s Q2 Earnings Call

The 5 Most Interesting Analyst Questions From ResMed's Q2 Earnings Call ResMed's second quarter saw steady revenue growth, but the market responded negatively as the company's operating margin declined year over year. Management attribute... Full story

Yahoo Finance • 2 months ago

ResMed (RMD) Q4 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Thursday, Aug. 6, 2026 at 4:30 p.m. ET CALL PARTICIPANTS Chief Investor Relations Officer-Salli Schwartz Chairman and Chief Executive Officer-Mick Farrell Chief Financial Officer-Aaron Bloomer Full... Full story

Yahoo Finance • 2 months ago

Resmed’s stock falls by 7% on soft FY27 outlook

Resmed's shares fell by around 7% after the company forecast a softer than expected fiscal year 2027 (FY27) outlook due to suspended ventilator sales, ongoing macro uncertainty and inflation across electronic components and freight. Relea... Full story

Yahoo Finance • 2 months ago

US Stock Market Today: S&P 500 Futures Climb On Softer Jobs Data And Yields

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. The Morning Bull - US Market Morning Update Monday, Aug, 10 2026 US stock futures are pointing hi... Full story

Yahoo Finance • 2 months ago

RMD Q2 Deep Dive: Margin Pressures Weigh Despite Product Momentum and Portfolio Shifts

RMD Q2 Deep Dive: Margin Pressures Weigh Despite Product Momentum and Portfolio Shifts Medical device company ResMed (NYSE:RMD) met Wall Street's revenue expectations in Q2 CY2026, with sales up 8.6% year on year to $1.46 billion. Its non... Full story

Yahoo Finance • 2 months ago

Stocks Supported as Fed Rate Hike Fears Ease

The S&P 500 Index ($SPX) (SPY) today is up +0.61%, the Dow Jones Industrial Average ($DOWI) (DIA) is up +0.25%, and the Nasdaq 100 Index ($IUXX) (QQQ) is up +1.00%.  September E-mini S&P futures (ESU26) are up +0.66%, and September E-mini... Full story

Yahoo Finance • 2 months ago

Stocks Rally on Earnings and Fed-Friendly US Payroll Report

The S&P 500 Index ($SPX) (SPY) today is up +0.37%, the Dow Jones Industrial Average ($DOWI) (DIA) is up +0.14%, and the Nasdaq 100 Index ($IUXX) (QQQ) is up +0.89%.  September E-mini S&P futures (ESU26) are up +0.44%, and September E-mini... Full story

Yahoo Finance • 2 months ago

ResMed Inc (RMD) (Q4 2026) Earnings Call Highlights: Strong Revenue Growth and Strategic ...

This article first appeared on GuruFocus. Revenue: Group revenue for Q4 FY2026 was $1.5 billion, a 9% headline increase and 8% growth on a constant currency basis. Non-GAAP Earnings Per Share: Increased by 16% to $2.95 in the fourth quart... Full story

Yahoo Finance • 2 months ago

ResMed Non-GAAP EPS of $2.95 beats by $0.06, revenue of $1.46B in-line

* ResMed press release [https://seekingalpha.com/pr/20611041-resmed-inc-announces-results-for-the-fourth-quarter-of-fiscal-year-2026] (RMD [https://seekingalpha.com/symbol/RMD]): Q4 Non-GAAP EPS of $2.95 beats by $0.06. * Revenue of $1... Full story

Yahoo Finance • 2 months ago

3 Large-Cap Stocks to Consider Right Now

3 Large-Cap Stocks to Consider Right Now Large-cap stocks have the power to shape entire industries thanks to their size and widespread influence. With such vast footprints, however, finding new areas for growth is much harder than for sm... Full story

Yahoo Finance • 3 months ago

3 Cash-Heavy Stocks to Research Further

3 Cash-Heavy Stocks to Research Further A clean balance sheet can signal disciplined management and stability. It also means a company can expand and thrive without relying on borrowed capital. Not all companies with sound capital struct... Full story

Yahoo Finance • 3 months ago

SpaceX initiated, Lululemon downgraded: Wall Street's top analyst calls

SpaceX initiated, Lululemon downgraded: Wall Street's top analyst calls The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compil... Full story

Yahoo Finance • 3 months ago

2 Mid-Cap Stocks with Exciting Potential and 1 We Ignore

2 Mid-Cap Stocks with Exciting Potential and 1 We Ignore Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets. But the many opportunities in front... Full story